GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | 8/14/2026 5:08:16 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $3,403,702 | EPS -$0.03 | ||
| Liminatus Pharma, Inc. (LIMN) | 7/13/2026 8:44:52 AM | View | Proxy | SEC | Y 2025 | ||||||
| Liminatus Pharma, Inc. (LIMN) | 5/15/2026 5:05:44 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $2,790,249 | EPS -$0.03 | ||
| Liminatus Pharma, Inc. (LIMN) | 3/31/2026 5:35:17 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | ||||
| Liminatus Pharma, Inc. (LIMN) | 11/14/2025 6:12:57 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | ||||
| Liminatus Pharma, Inc. (LIMN) | 10/6/2025 6:16:15 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | ||||
| Liminatus Pharma, Inc. (LIMN) | 6/2/2025 6:14:55 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 |